Zynfuse
Zynfuse
Engineered for surgical precision, biomechanical stability, and robust long-term clinical outcomes.
Elevating Clinical Efficiency and Mechanical Integrity in Trauma and Spinal Interventions.
Traditional bone fixation systems demand a meticulous pre-tapping step, which extends operating room (OR) durations and elevates the risk of bone thermal necrosis. Our advanced Self-Tapping Bone Screws incorporate a specialized cutting flute at the distal tip. This micro-engineered geometry cuts its own thread path as it advances, eliminating the pre-tapping stage, lowering friction, and preserving the local bone microarchitecture.
By optimizing thread profile parameters—including pitch, depth, and flute geometry—Zynfuse screws establish superior initial mechanical purchase and high pull-out resistance. This is vital in osteoporotic bone conditions, where structural density is compromised. Our self-tapping configurations maximize surface contact with cortical and cancellous bone, significantly minimizing the rates of early implant loosening.
Utilizing high-grade medical titanium alloys (Ti-6Al-4V ELI) compliant with ASTM F136 standards, Zynfuse implants offer excellent tissue integration. The passive titanium oxide surface layer prevents metallic ion leakage and supports rapid, stable osseointegration. This ensures robust bio-stability across internal fixation configurations, from trauma plates to spinal osteosynthesis constructs.
Providing clinical innovations and global supply assurance for orthopedic device supply chains.
Established in 2016, Zynfuse Medical Technology Co., Ltd. has established itself as an innovative force in the global orthopedic device manufacturing sector. Anchored by 12 years of industry experience and 7 years of specialized export expertise, Zynfuse delivers precision bone fusion systems and surgical instrumentation sets to demanding international medical channels. Our headquarters and modern production facilities encompass 18,600 m² of optimized industrial footprint, utilizing Swiss-type lathes, multi-axis CNC machines, and Class 10,000 cleanroom environments to meet stringent global standards.
Zynfuse operates a highly responsive supply chain, partnering with over 1,200 global distributors, healthcare groups, and orthopaedic clinics. By maintaining an annual export valuation exceeding $18.5 Million, we serve critical medical markets across North America, Europe, Southeast Asia, and the Middle East. Our product portfolio is dynamic: our R&D team of 85 senior engineers launches approximately 320 new products annually, enabling agile OEM/ODM product adjustments to accommodate localized clinical standards and preferences.
Detailed visual walkthrough of Zynfuse's medical manufacturing processes and technology.
68 quality inspection specialists monitoring mechanical integrity and sterile verification.
Navigating global certifications and strict quality barriers to ensure safe patient outcomes.
Entering international medical markets requires strict regulatory alignment. Our quality control architecture is structured around ISO 13485:2016 medical quality management systems. Zynfuse self-tapping bone screws and accompanying instruments comply with Class III medical registration benchmarks, CE certifications, and sterilization validations (EN ISO 11137). Each production batch undergoes strict mechanical evaluation, testing axial pull-out force, insertion torque, and torsional yield strength in accordance with ASTM F543 guidelines.
Our localized support structure facilitates registration procedures for regional distributors. We provide comprehensive technical dossier packages (including DHF, DMR, Biocompatibility Evaluation Reports complying with ISO 10993, and Clinical evaluation folders) to accelerate regional approvals, including CE MDR and domestic FDA submissions. Through customized logistics agreements and sterile double-barrier packaging, Zynfuse guarantees reliable delivery times and secure customs clearances worldwide.
The next evolution of bone fusion technology: bioresorbables, coatings, and digital integration.
Research indicates that micro-structured surfaces enhance early bone-to-implant contact. Zynfuse is actively developing a Type II Anodized and Hydroxyapatite (HA) coating pipeline. This biochemical layout accelerates osteoblast activation and enhances mineralization around the thread tracks, improving primary implant stability in compromised bone environments.
To eliminate second-look surgeries for implant removal, our R&D division is designing bioabsorbable self-tapping screws using high-grade Poly-L-lactide (PLLA) and magnesium alloy substrates. These materials provide robust initial structural support during bone healing and gradually degrade, transferring load naturally back to the bone.
By pairing 3D printing (Electron Beam Melting) with precise Swiss-turning processes, we are developing hollow and trabecular self-tapping screws. These porous configurations facilitate bone ingrowth through the implant core, leading to improved long-term integration for complex reconstructive surgeries.
Expert technical answers addressing surgical applications, material properties, and distributor logistics.
Certified medical innovations designed for bone fusion, trauma restoration, and joint reconstruction.
